Quantcast

Latest pharmaceutical industry Stories

2014-07-17 08:28:49

MUMBAI, July 17, 2014 /PRNewswire/ -- - The Facility Will be Situated in Monroe, North Carolina, USA - It Will Manufacture Oral Solids, Injectables and Topicals Over a Five Year Period Glenmark Pharmaceuticals Ltd, a research-driven, global, integrated pharmaceutical company, plans to set up a new manufacturing facility in the US. The company plans to set up this manufacturing facility at Monroe Corporate Center, North Carolina, USA. The facility will be spread...

2014-07-17 08:28:41

SANTA ROSA, Calif., July 17, 2014 /PRNewswire/ -- Ruthigen, Inc., (NASDAQ: RTGN) today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014. In June 2014, Ruthigen's Investigational New Drug (IND) application became effective following review by the U.S. Food and Drug Administration (FDA). Ruthigen is developing RUT58-60 as a safe and fast...

2014-07-17 08:28:30

Unprecedented High Drug Costs to Force Major Financial Tradeoffs for State Budgets ST. LOUIS, July 17, 2014 /PRNewswire/ -- State legislatures will need to find billions in their budgets to purchase costly new hepatitis C therapy, according to a new state-by-state analysis released today by Express Scripts (NASDAQ: ESRX). http://photos.prnewswire.com/prnvar/20080827/EXPRESSSCRIPTSLOGO More than 750,000 Americans with chronic hepatitis C receive state-funded healthcare through Medicaid or the...

2014-07-17 08:28:25

ANDERNACH, Germany, July 17, 2014 /PRNewswire/ -- - LTS: market leader in transdermal patches completely acquired by dievini Hopp The supervisory board ("Aufsichtsrat") and management board ("Vorstand") of LTS have concluded the assessment of strategic options for the future development of the LTS group. LTS developed innovative, value oriented growth strategies identifying also the prerequisites for the successful strategy implementation. Meanwhile, LTS's major...

2014-07-17 08:28:14

LONDON, July 17, 2014 /PRNewswire/ -- PharmaBoardroom's "Healthcare and Life Sciences Review Poland 2014 [http://pharmaboardroom.com/country_reports/poland-2 ]", is now available for free download [http://pharmaboardroom.com/country_reports/poland-2 ]. The report [http://pharmaboardroom.com/country_reports/poland-2 ] explores one of Europe's largest pharma markets, and looks at the delicate balance between a strong and growing economy, and healthcare legislation that many...

2014-07-17 04:20:56

GENEVA, July 17, 2014 /PRNewswire/ -- MPP forges first agreement with a Chinese manufacturer Desano; and with Cipla, Mylan and Micro Labs; Extends Collaborations with Aurobindo, Laurus Labs and Emcure Three days before the start of the 20th International AIDS Conference in Melbourne, Australia, the Medicines Patent Pool (MPP) announced seven new sub-licensing agreements for the manufacture of generic HIV medicines, atazanavir (ATV) and dolutegravir (DTG). The...

2014-07-17 04:20:49

LUGANO, Switzerland and TOKYO, July 17, 2014 /PRNewswire/ -- Under the exclusive agreement, Chugai Pharma Marketing gains rights for the marketing of palonosetron in the UK and NEPA in the UK and in Ireland from Helsinn Group, strengthening the existing alliance between the companies in therapeutic area of supportive cancer care. Helsinn, the Swiss Group focused on building quality cancer care, and Chugai Pharmaceutical Co., Ltd. today announced that exclusive rights to...

2014-07-16 20:22:18

LONDON, July 16, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: In-Vitro Diagnostics Market Outlook 2018 https://www.reportbuyer.com/product/2080563/In-Vitro-Diagnostics-Market-Outlook-2018.html Driven by factors, such as increasing prevalence of chronic diseases, rising demand for POCT and technological advancements in the global market, the IVD market is going through a very exciting phase. Presently, the market is dominated by developed countries;...

2014-07-16 16:24:01

ABERDEEN, Scotland and SINGAPORE, July 16, 2014 /PRNewswire/ -- TauRx Therapeutics Ltd [http://www.taurx.com ] announced it has achieved its target enrollment of 833 subjects into one of its two ongoing multi-center Phase III clinical trials of LMTX(TM) [http://taurx.com/lmtx-for-ad ], a tau aggregation inhibitor, for the treatment of Alzheimer's Disease [AD]. This placebo-controlled clinical trial (Protocol TRx-237-015 [http://taurx.com/015-clinical-study.html ]) has...

2014-07-16 12:27:23

COSTA MESA, Calif., July 16, 2014 /PRNewswire-iReach/ -- WCCT Global, a contract research organization headquartered in Southern Californian announced today the successful completion of a large phase I clinical trial. The study protocol required that WCCT Global enroll 180 patients that would stay in their phase I Clinical Pharmacology Unit for an extended period of time. WCCT Global was able to randomize and accommodate all the needed patient cohorts without delays. WCCTG...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related